These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 18182964)

  • 1. Clonidine for attention-deficit/hyperactivity disorder: II. ECG changes and adverse events analysis.
    Daviss WB; Patel NC; Robb AS; McDERMOTT MP; Bukstein OG; Pelham WE; Palumbo D; Harris P; Sallee FR;
    J Am Acad Child Adolesc Psychiatry; 2008 Feb; 47(2):189-198. PubMed ID: 18182964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clonidine for attention-deficit/hyperactivity disorder: I. Efficacy and tolerability outcomes.
    Palumbo DR; Sallee FR; Pelham WE; Bukstein OG; Daviss WB; McDERMOTT MP;
    J Am Acad Child Adolesc Psychiatry; 2008 Feb; 47(2):180-188. PubMed ID: 18182963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clonidine for treatment of attention-deficit/hyperactivity disorder.
    Med Lett Drugs Ther; 1996 Dec; 38(989):109-10. PubMed ID: 8957471
    [No Abstract]   [Full Text] [Related]  

  • 4. Revisiting clonidine: an innovative add-on option for attention-deficit/hyperactivity disorder.
    Childress AC; Sallee FR
    Drugs Today (Barc); 2012 Mar; 48(3):207-17. PubMed ID: 22462040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A pilot study of methylphenidate, clonidine, or the combination in ADHD comorbid with aggressive oppositional defiant or conduct disorder.
    Connor DF; Barkley RA; Davis HT
    Clin Pediatr (Phila); 2000 Jan; 39(1):15-25. PubMed ID: 10660814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of clonidine and methylphenidate on family quality of life in attention-deficit/hyperactivity disorder.
    Cannon M; Pelham WH; Sallee FR; Palumbo DR; Bukstein O; Daviss WB
    J Child Adolesc Psychopharmacol; 2009 Oct; 19(5):511-7. PubMed ID: 19877975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of ADHD in children with tics: a randomized controlled trial.
    Tourette's Syndrome Study Group
    Neurology; 2002 Feb; 58(4):527-36. PubMed ID: 11865128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Functioning, comorbidity and treatment of 141 adults with attention deficit hyperactivity disorder (ADHD) at a psychiatric outpatient department].
    Kooij JJ; Aeckerlin LP; Buitelaar JK
    Ned Tijdschr Geneeskd; 2001 Aug; 145(31):1498-501. PubMed ID: 11512422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immediate-release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults.
    Epstein T; Patsopoulos NA; Weiser M
    Cochrane Database Syst Rev; 2014 Sep; (9):CD005041. PubMed ID: 25230710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Attention deficit disorder with hyperactivity in children: diagnosis and therapeutic management].
    Vallée L
    Arch Pediatr; 2000 Oct; 7(10):1111-6. PubMed ID: 11075268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combining methylphenidate and clonidine: a clinically sound medication option.
    Wilens TE; Spencer TJ; Swanson JM; Connor DF; Cantwell D
    J Am Acad Child Adolesc Psychiatry; 1999 May; 38(5):614-9; discussion 619-22. PubMed ID: 10230195
    [No Abstract]   [Full Text] [Related]  

  • 12. Randomized, Double-Blind, Placebo-Controlled Acute Comparator Trials of Lisdexamfetamine and Extended-Release Methylphenidate in Adolescents With Attention-Deficit/Hyperactivity Disorder.
    Newcorn JH; Nagy P; Childress AC; Frick G; Yan B; Pliszka S
    CNS Drugs; 2017 Nov; 31(11):999-1014. PubMed ID: 28980198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of OROS methylphenidate in adults with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled, double-blind, parallel group, dose-escalation study.
    Adler LA; Zimmerman B; Starr HL; Silber S; Palumbo J; Orman C; Spencer T
    J Clin Psychopharmacol; 2009 Jun; 29(3):239-47. PubMed ID: 19440077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methylphenidate an effective treatment for ADHD?
    McDougle CJ
    J Autism Dev Disord; 2004 Oct; 34(5):593-4. PubMed ID: 15628613
    [No Abstract]   [Full Text] [Related]  

  • 15. Insomnia, night terror, and depression related to clonidine in attention-deficit/hyperactivity disorder.
    Ghanizadeh A
    J Clin Psychopharmacol; 2008 Dec; 28(6):725-6. PubMed ID: 19011458
    [No Abstract]   [Full Text] [Related]  

  • 16. Transition from methylphenidate or amphetamine to atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder--a preliminary tolerability and efficacy study.
    Quintana H; Cherlin EA; Duesenberg DA; Bangs ME; Ramsey JL; Feldman PD; Allen AJ; Kelsey DK
    Clin Ther; 2007 Jun; 29(6):1168-77. PubMed ID: 17692731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and Safety of HLD200, Delayed-Release and Extended-Release Methylphenidate, in Children with Attention-Deficit/Hyperactivity Disorder.
    Pliszka SR; Wilens TE; Bostrom S; Arnold VK; Marraffino A; Cutler AJ; López FA; DeSousa NJ; Sallee FR; Incledon B; Newcorn JH
    J Child Adolesc Psychopharmacol; 2017 Aug; 27(6):474-482. PubMed ID: 29172680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clonidine extended-release tablets for pediatric patients with attention-deficit/hyperactivity disorder.
    Jain R; Segal S; Kollins SH; Khayrallah M
    J Am Acad Child Adolesc Psychiatry; 2011 Feb; 50(2):171-9. PubMed ID: 21241954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atomoxetine versus methylphenidate in paediatric outpatients with attention deficit hyperactivity disorder: a randomized, double-blind comparison trial.
    Wang Y; Zheng Y; Du Y; Song DH; Shin YJ; Cho SC; Kim BN; Ahn DH; Marquez-Caraveo ME; Gao H; Williams DW; Levine LR
    Aust N Z J Psychiatry; 2007 Mar; 41(3):222-30. PubMed ID: 17464703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of a novel biphasic controlled-release methylphenidate formula in adults with attention-deficit/hyperactivity disorder: results of a double-blind, placebo-controlled crossover study.
    Jain U; Hechtman L; Weiss M; Ahmed TS; Reiz JL; Donnelly GA; Harsanyi Z; Darke AC
    J Clin Psychiatry; 2007 Feb; 68(2):268-77. PubMed ID: 17335326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.